Skip to content
Original research

State of AI therapy scribes 2026

Aggregate editorial data across the 14 AI therapy scribes we track — where the category is strong, where it's still uneven, and where solo and group practices should focus.

Verified Re-verified quarterly
Reviewed by TherapyScribes EditorialFacts verified Methodology

Key takeaways

  • 14 of 14 tracked scribes sign HIPAA BAAs — up from ~50% at the start of 2025.
  • Only 4 of 14 offer a real ongoing free tier — Upheal remains the standout.
  • Average note-quality score across the category is 7.8/10; average compliance is 8.0/10.
  • Multilingual support is still the biggest gap — 7 of 14 vendors go beyond English.
14/14
Tracked vendors that sign a HIPAA BAA
BAA availability is now table stakes for any vendor claiming behavioral-health fit. The remaining 0 that don't should be treated as consumer tools, not clinical.

Category averages

7.8
Note quality (0-10)
Weighted mean across the tracked catalog.
8.0
Compliance (0-10)
BAA, trust page, SOC 2 posture.
8.0
Pricing (0-10)
Value at entry tier, adjusted for BAA availability.

Full editorial dataset

ScribeNote qualityComplianceIntegrationPricingBreadthSupportOverall
Twofold Health9.48.87.89.88.88.89.3
Upheal8.88.57.59.29.08.08.7
Mentalyc8.68.47.07.89.28.08.4
Heidi Health8.48.67.29.08.48.08.3
Blueprint8.08.27.27.67.88.48.2
Freed8.08.07.07.67.48.27.9
Eleos Health8.08.68.25.58.48.27.9
AutoNotes7.67.46.88.48.67.27.6
Supanote7.27.06.58.87.07.07.4
Lyrebird Health7.48.27.07.07.07.47.3
Yung Sidekick7.06.86.57.56.87.07.2
Clinical Notes AI7.07.26.57.27.47.07.1
Nabla Copilot7.49.28.08.06.47.87.0
NoteDesigner7.07.65.58.47.27.06.8

Where the category is heading

Three trends are shaping 2026. First, therapy-first vendors have caught up on compliance — BAAs, encryption, no-training defaults — narrowing the moat that enterprise scribes used to hold. Second, treatment-plan continuity (goals persisting across sessions) is emerging as the real differentiator, replacing raw transcription accuracy which has plateaued near 95%+ across the field. Third, native EHR write-back remains the industry's biggest gap: copy-paste is still the norm even for scribes marketed as "SimplePractice-compatible".

For solo practice, the tools have converged enough that price and template fit matter more than raw quality. For CMHC and enterprise, the field remains thin — Eleos Health and Nuance DAX Copilot are the two credible enterprise options, with a wide gap to the next tier.

Methodology

Scores are editorial, based on the rubric documented on our methodology page. Every vendor claim is verified against the vendor's own public documentation and dated in our changelog.

Cite this page

TherapyScribes.review. State of AI therapy scribes 2026. 2026-06-20. https://comparetherapyscribe.com/research